Clinical trial
Effects of Remimazolam and Propofol on Heart Rate Variability in Type 2 Diabetes Patients During Anesthesia Induction
NCT06009055 is registered in ClinicalTrials.gov with Zheng Guo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Remimazolam and Propofol on Heart Rate Variability in Type 2 Diabetes Patients During Anesthesia Induction
- Lead sponsor
- Zheng Guo
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 17, 2023
- Completion date
- December 31, 2024
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes